razoxane has been researched along with Polyploid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eastmond, DA; Roy, SK | 1 |
| Abram, ME; Barnabé, N; Byard, EH; Chee, GL; Ferrans, VJ; Hasinoff, BB; Huebner, E; Yalowich, JC; Yu, ZX | 1 |
| Ferrans, VJ; Hasinoff, BB; Takeda, K; Yu, ZX | 1 |
| Bleehen, NM; Taylor, IW | 1 |
4 other study(ies) available for razoxane and Polyploid
| Article | Year |
|---|---|
Bimolane induces multiple types of chromosomal aberrations in human lymphocytes in vitro.
Topics: Antineoplastic Agents; Cells, Cultured; Chromosome Aberrations; Humans; In Situ Hybridization, Fluorescence; Leukemia; Lymphocytes; Male; Micronuclei, Chromosome-Defective; Mutagens; Neoplasms, Second Primary; Nondisjunction, Genetic; Polyploidy; Razoxane | 2011 |
The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces endopolyploidy in Chinese hamster ovary cells.
Topics: Animals; Antineoplastic Agents; Catalysis; Cell Division; CHO Cells; Cricetinae; DNA; Enzyme Inhibitors; Kinetics; Microscopy, Electron; Microscopy, Fluorescence; Polyploidy; Razoxane; Topoisomerase II Inhibitors | 2000 |
The doxorubicin cardioprotective agent dexrazoxane (ICRF-187) induces endopolyploidy in rat neonatal myocytes through inhibition of DNA topoisomerase II.
Topics: Animals; Animals, Newborn; Antineoplastic Agents; Cardiovascular Agents; Cell Cycle; Cell Division; DNA; Dose-Response Relationship, Drug; Doxorubicin; Heart Ventricles; Microscopy, Confocal; Myocardium; Polyploidy; Rats; Rats, Sprague-Dawley; Razoxane; Topoisomerase II Inhibitors | 2002 |
Razoxane-induced polyploidy.
Topics: Cell Division; Cell Line; Chromosomes; DNA, Neoplasm; Neoplasms, Experimental; Piperazines; Polyploidy; Razoxane | 1978 |